Preoperative addition of anti-angiogenic bevacizumab to standard induction cisplatin/pemetrexed does not increase the risk of acute postoperative bleeding after surgery for malignant mesothelioma

O. Lauk, K. Brüstle, M. Friess, Thi Dan L. Nguyen, T. Frauenfelder, R. Stahel, W. Weder, I. Opitz